SIRPA and colorectal cancer: Combined therapy with radiotherapy/anti-SIRPα/anti-PD-1 for colorectal cancer was shown to effectively induce cGAS–STING signaling in DCs both in vitro and in vivo, facilitating efficient cross-presentation of tumor-associated antigens (53, 54).